Discordant responses of plasma low-density lipoprotein cholesterol and lipoprotein(a) to alirocumab: A pooled analysis from 10 ODYSSEY Phase 3 studies
Mahmood, Tahir, Minnier, Jessica, Ito, Matthew K, Li, Qian H, Koren, Andrew, Kam, Ivy W, Fazio, Sergio, Shapiro, Michael DJournal:
European Journal of Preventive Cardiology
DOI:
10.1177/2047487320915803
Date:
April, 2020
File:
PDF, 578 KB
2020